Indian pharmaceutical company Lupin (NSE:LUPIN, BOM:500257) has completed the acquisition of a 42.61% stake in renewable energy company Sunsure Solarpark Seventeen, according to a Thursday filing to the stock exchanges.
In September 2024, Lupin had agreed to acquire up to 42.61% stake in Sunsure Solarpark Seventeen for up to 105.53 million Indian rupees, to be completed in two tranches.
Price (INR): ₹2256.35, Change: ₹+3.5, Percent Change: +0.16%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。